Attached files
| file | filename |
|---|---|
| 10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Jazz Pharmaceuticals plc | d10ka.htm |
| EX-31.3 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | dex313.htm |
EXHIBIT 31.4
CERTIFICATION
I, Kathryn Falberg, certify that:
| 1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Jazz Pharmaceuticals, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| Date: March 24, 2010 | By: | /s/ Kathryn Falberg | ||
| Kathryn Falberg | ||||
| Chief Financial Officer | ||||